Rigel Pharmaceuticals (RIGL) EBT Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -176.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -176.00 |
| Dec 31, 2025 | 611.00 |
| Sep 30, 2025 | 1,730.00 |
| Jun 30, 2025 | 6,178.00 |
| Mar 31, 2025 | 4,951.00 |
| Dec 31, 2024 | 2,437.00 |
| Sep 30, 2024 | 4,269.00 |
| Jun 30, 2024 | 2,175.00 |
| Mar 31, 2024 | 2,400.00 |
| Dec 31, 2023 | -67.00 |
| Sep 30, 2023 | 6,472.00 |
| Jun 30, 2023 | 2,070.00 |
| Mar 31, 2023 | 11,208.00 |
| Dec 31, 2022 | 11,396.00 |
| Sep 30, 2022 | 1,294.00 |
| Jun 30, 2022 | 1,107.00 |
| Mar 31, 2022 | -21,494.00 |
| Dec 31, 2021 | -696.00 |
| Sep 30, 2021 | -2,081.00 |
| Jun 30, 2021 | 5,339.00 |
| Mar 31, 2021 | 1,284.00 |
| Dec 31, 2020 | 742.00 |
| Sep 30, 2020 | -2,199.00 |
| Jun 30, 2020 | 8,830.00 |
| Mar 31, 2020 | 17,750.00 |
| Dec 31, 2019 | -12,022.00 |
| Sep 30, 2019 | 43,342.00 |
| Jun 30, 2019 | 123,216.00 |
| Dec 31, 2018 | -56,844.00 |
| Sep 30, 2018 | 147,371.00 |
| Dec 31, 2017 | 109,956.00 |
| Sep 30, 2017 | -136,039.00 |
| Mar 31, 2017 | -10,045.00 |
| Dec 31, 2016 | -37,399.00 |
| Sep 30, 2016 | -55,007.00 |
| Jun 30, 2016 | 11,089.00 |
| Mar 31, 2016 | 48,804.00 |
| Jun 30, 2013 | 2,291.00 |
| Jun 30, 2012 | 378,726.00 |
| Sep 30, 2011 | -48,151.00 |
| Jun 30, 2011 | -549,111.00 |